相关实验视频

Updated: May 11, 2026

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.6K

作为恶性多叶膜间皮瘤 (NEMO) 交换维护治疗的宁达尼布:一项双盲随机二期试验 (EORTC-08112-LCG)

Omar Abdel-Rahman1, Paul Taylor2, Mary O'Brien3

  • 1Medical Oncology, University of Alberta and Cross Cancer Institute, Edmonton, Canada.

Lung cancer (Amsterdam, Netherlands)
|January 15, 2026
PubMed
概括

交换维护:尼丁达尼布并没有改善无进展存活率或质间皮瘤患者的整体存活率. 这项研究表明了潜在的混因素,包括安慰剂组中不平衡的免疫疗法使用.

关键词:
维护 维护 维护 维护尼丁达尼比尼是什么意思胸腔半质瘤是多发性半质瘤.幸存的生存方式

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.9K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.3K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...